Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 26, 2026

1 AI Stock I Wouldn't Touch, and 1 I Absolutely Love

View original at nasdaq.com
“In Q4, the company reported a generally accepted accounting principles (GAAP) net loss of $12.1 million.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Apple gives investors a front-row seat to the consumer AI revolution while providing the safety of a highly profitable, cash-generating business

    60% confidence
  • Stock Advisor's total average return is 900% compared to 184% for the S&P 500

    60% confidence
  • New annual contract value bookings grew by nearly 50% year over year

    60% confidence
  • Apple wasn't one of the 10 best stocks for investors to buy now

    60% confidence
  • Apple is well-positioned to capture a multiyear wave of high-margin device sales while also tapping new software and services opportunities in an AI era

    60% confidence
  • Apple will likely be a major AI beneficiary without having to invest the same extraordinary sums that software and cloud providers do

    60% confidence
  • Cloudflare's inability to turn a true profit makes its sky-high valuation too risky

    60% confidence
  • Apple's stock has a bullish outlook over the next five years

    60% confidence

Data points we hold from this source

Apple Podcasts · price to earnings ratio32 ratio
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com